Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
a9-dpc (1 trial)
autologous adipose-derived mesenchymal stem cells (1 trial)
autologous skin fibroblasts (1 trial)
fetal-derived neural stem cells (1 trial)
Ischemia (Phase 2)
Trials (4 total)
Trial APIs (4 total)